Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2026-02-22 @ 1:00 PM
Study NCT ID:
NCT03329950
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2017-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Sponsor:
Celldex Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
| None | Non-small Cell Lung Cancer | View |
| None | Breast Cancer | View |
| None | Gastric Cancer | View |
| None | Renal Cell Carcinoma | View |
| None | Ovarian Cancer | View |
| None | Cholangiocarcinoma | View |
| None | Bladder Urothelial Carcinoma | View |
| None | Pancreatic Adenocarcinoma | View |
| None | Colorectal Cancer | View |
| None | Esophageal Cancer | View |
| None | Hepatic Cancer | View |
| None | Head and Neck Cancer | View |
| None | Primary Peritoneal Cancer | View |
| None | Fallopian Tube Cancer | View |
| None | Other Solid Tumors | View |
| None | Diffuse Large B-cell Lymphoma (DLBCL) | View |
| None | Mantle Cell Lymphoma | View |
| None | Indolent B-cell Lymphomas | View |
| None | Non-Hodgkin Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Lymphoplasmacytic Lymphoma | View |
| None | Waldenstrom's Disease | View |
| None | Marginal Zone Lymphoma | View |
| None | Mucosa Associated Lymphoid Tissue | View |
| None | Small Lymphocytic Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | CDX-1140 | View |
| None | Solid Tumors | View |
| None | Liver Cancer | View |
| None | GI Cancer | View |
| None | Kidney Cancer | View |
| None | Celldex | View |
| None | Monoclonal | View |
| None | Antibody | View |
| None | CD40 | View |
| None | CD-40 | View |
| None | Flt3l | View |
| None | CDX-301 | View |
| None | Lung Cancer | View |
| None | Bile duct cancer | View |
| None | TNBC | View |
| None | RCC | View |
| None | Non-Hodgkin Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Dendritic cell | View |
| None | Keynote A-23 | View |
| None | pembrolizumab | View |
| None | Keytruda | View |
| None | Chemotherapy | View |
| None | Gemcitabine | View |
| None | Nab-paclitaxel | View |
| None | CD40L | View |
| None | CD40 Ligand | View |
| None | Pancreas cancer | View |
| None | Metastatic pancreas cancer | View |
| None | Unresectable pancreas cancer | View |
| None | Stage IV pancreas cancer | View |
| None | Squamous cell cancer lung | View |
| None | Non-squamous cell cancer lung | View |
| None | Metastatic lung cancer | View |
| None | Stage IV lung cancer | View |
| None | Squamous cell cancer of head and neck | View |
| None | Stage IV cancer of head and neck | View |
| None | Throat cancer | View |
| None | Oropharyngeal cancer | View |
| None | Laryngeal cancer | View |
| None | Oral cancer | View |
| None | FLT3 Ligand | View |
| None | fms-like tyrosine kinase 3 ligand | View |
| None | KEYTRUDA® | View |